Diabetes 53:2024-2033, 2004
© 2004 by the American Diabetes Association, Inc.
Inhibition of Activin Signaling Induces Pancreatic Epithelial Cell Expansion and Diminishes Terminal Differentiation of Pancreatic ß-Cells
You-Qing Zhang1,
Mary Malo Cleary1,
Yingjie Si1,
Guoxun Liu1,
Yuzuru Eto2,
Marcie Kritzik1,
Sandrine Dabernat1,
Ayse G. Kayali1, and
Nora Sarvetnick1
1 Department of Immunology, The Scripps Research Institute, La Jolla, California
2 Pharmaceutical Research Laboratories, Ajinomoto Co., Kawasaki, Japan
Activins regulate the growth and differentiation of a variety of cells. During pancreatic islet development, activins are required for the specialization of pancreatic precursors from the gut endoderm during midgestation. In this study, we probed the role of activin signaling during pancreatic islet cell development and regeneration. Indeed, we found that both activins and activin receptors are upregulated in duct epithelial cells during islet differentiation. Interestingly, the expression of endogenous cellular inhibitors of activin signaling, follistatin and Cripto, were also found to be augmented. Inhibition of activins significantly enhanced survival and expansion of pancreatic epithelial cells but decreased the numbers of differentiated ß-cells. Our results suggest that the homeostasis of growth and terminal differentiation requires a precise context-dependent regulation of activin signaling. Follistatin participates in this process by promoting expansion of precursor cells during pancreas growth.
Address correspondence and reprint requests to Nora Sarvetnick, PhD, Department of Immunology, IMM23, The Scripps Research Institute, La Jolla, CA 92037. E-mail: noras{at}scripps.edu

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Eijken, S. Swagemakers, M. Koedam, C. Steenbergen, P. Derkx, A. G. Uitterlinden, P. J. van der Spek, J. A. Visser, F. H. de Jong, H. A. P. Pols, et al.
The activin A-follistatin system: potent regulator of human extracellular matrix mineralization
FASEB J,
September 1, 2007;
21(11):
2949 - 2960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Simeone, L. Zhang, M. K. Treutelaar, L. Zhang, K. Graziano, C. D. Logsdon, and C. F. Burant
Islet hypertrophy following pancreatic disruption of Smad4 signaling
Am J Physiol Endocrinol Metab,
December 1, 2006;
291(6):
E1305 - E1316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hua, Y.-Q. Zhang, S. Dabernat, M. Kritzik, D. Dietz, L. Sterling, and N. Sarvetnick
BMP4 Regulates Pancreatic Progenitor Cell Expansion through Id2
J. Biol. Chem.,
May 12, 2006;
281(19):
13574 - 13580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Chute, G. G. Muramoto, H. K. Dressman, G. Wolfe, N. J. Chao, and S. Lin
Molecular Profile and Partial Functional Analysis of Novel Endothelial Cell-Derived Growth Factors that Regulate Hematopoiesis
Stem Cells,
May 1, 2006;
24(5):
1315 - 1327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Harmon, A. A. Apelqvist, N. G. Smart, X. Gu, D. H. Osborne, and S. K. Kim
GDF11 modulates NGN3+ islet progenitor cell number and promotes {beta}-cell differentiation in pancreas development
Development,
December 15, 2004;
131(24):
6163 - 6174.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Diabetes Association.
|
|
| |
|